Crossmark

Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks

Crossref DOI link: https://doi.org/10.1186/s12959-021-00279-6

Published Online: 2021-04-29

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ng, Andrew Kei-Yan

Ng, Pauline Yeung

Tam, Eva Wai-Ying

Siu, Chung-Wah

Fan, Katherine
License Information

Text and Data Mining valid from 2021-04-29

Version of Record valid from 2021-04-29
More Information

Article History

Received: 11 February 2021

Accepted: 13 April 2021

First Online: 29 April 2021

Declarations

:

: The study was approved by the Institutional Review Board of the University of Hong Kong / Hospital Authority, and a waiver of informed consent was granted.

: All authors consent to publication.

: Nil.

Document is current

Any future updates will be listed below